tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market

Anbio Biotechnology Class A (NNNN) Revenue

Compare
5 Followers

Anbio Biotechnology Class A Revenue

Anbio Biotechnology Class A had a revenue of 2.53M in the quarter ending Dec 31, 2024, with -60.01%. This bring the company's revenue in the last twelve months to 8.85M, Increased -13.85%. In the fiscal year ending Dec 31, 2024, Anbio Biotechnology Class A had annual revenue of 8.19M with 21.95% growth.
Revenue (ttm)
8.85M
Revenue Growth
P/S Ratio
152.50
Revenue/Employee
Employees
Market Cap
$1.25B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.19M1.47M+21.95%
Dec 31, 2023
6.71M-16.83M-71.49%
Dec 31, 2022
23.54M19.12M+431.67%
Dec 31, 2021
4.43M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis